Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients
about
Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesIVIG regulates the survival of human but not mouse neutrophils.Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis.Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin.Identification of novel plasma glycosylation-associated markers of aging.Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye.bIgG time for large eaters: monocytes and macrophages as effector and target cells of antibody-mediated immune activation and repression.Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies.Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patients
P2860
Q28069362-9C07E641-3C31-48DF-AFDA-E07F119B587BQ33683531-CD61EA23-EA7A-4B24-8C27-33E6884D2A1CQ35590264-5B8EF743-7056-4926-9502-834A4008E740Q36255087-BDF4728C-07BD-42FC-B15D-CF291D6D73F8Q36500575-9D569BD9-2545-4E2B-B15A-B478B08C7471Q36946538-5AFE62E4-FE91-4A05-90D3-7A2D13BD9485Q37713650-BDD7A712-E5B2-4C23-9D13-0030F9A82196Q38478867-2243D57F-3967-4129-B47E-E582F927F44AQ38615353-BBEE34C1-AAE7-4464-AA43-5C9BCE1AE693Q38900642-5EB17397-8AC1-45F5-858F-98B46B721BD5Q47804590-FE52CA8A-0511-4509-BDA4-9C15FD72A946Q58861212-71CDD7D8-7DAC-43F2-9971-71F39100959F
P2860
Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravenous immunoglobulin-ind ...... pansion in autoimmune patients
@en
Intravenous immunoglobulin-ind ...... ansion in autoimmune patients.
@nl
type
label
Intravenous immunoglobulin-ind ...... pansion in autoimmune patients
@en
Intravenous immunoglobulin-ind ...... ansion in autoimmune patients.
@nl
prefLabel
Intravenous immunoglobulin-ind ...... pansion in autoimmune patients
@en
Intravenous immunoglobulin-ind ...... ansion in autoimmune patients.
@nl
P2093
P2860
P50
P356
P1433
P1476
Intravenous immunoglobulin-ind ...... pansion in autoimmune patients
@en
P2093
Chaitrali Saha
Emmanuel Stephen-Victor
Luc Mouthon
Meenu Sharma
Mohan S Maddur
Olivier Benveniste
Yoland Schoindre
P2860
P2888
P356
10.1038/SREP05672
P407
P577
2014-07-11T00:00:00Z
P5875
P6179
1007241171